July 2026
The global CAR T-cell therapy market size is calculated at USD 5,206.15 million in 2025 and is projected to surpass around USD 26,982.3 million by 2035 with a solid CAGR of 17.88%.
September 2026
The U.S. CAR T-cell therapy market size stood at USD 2,684.84 million in 2026, with major U.S. CAR T-cell therapy market companies including Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences, Inc.
September 2026
The US cell and gene therapy market generated USD 4.74 billion in 2026, with prominent US cell and gene therapy market companies including Alnylam Pharmaceuticals Inc., Amgen Inc., Biogen Inc., CORESTEM Inc.
August 2025
The intravenous (IV) hydration therapy market size reached USD 2.71 billion in 2024 and is projected to surpass around USD 5.84 billion by 2034, with a notable CAGR of 7.98%.
September 2026
The global in vivo CAR-T therapy market size was evaluated at USD 861.25 million in 2026 and is predicted to hit around USD 10,841.07 million by 2035, growing at a CAGR of 32.50%.
July 2026
The global cardiac resynchronization therapy market size is projected to hit around USD 18.33 billion by 2035 from USD 9.05 billion in 2025 with a CAGR of 7.31%.
June 2026
The global T-cell immunotherapy market size is estimated to hit around USD 29.45 billion by 2035 increasing from USD 8.43 billion in 2025, with a CAGR of 13.33%.
February 2026
The global T-cell therapy market size is reached at USD 10.30 billion in 2025 and it is expected to hit around USD 196.21 billion by 2035 with a CAGR of 34.27%.
September 2026
The global used car market size is exhibited at USD 136.06 trillion in 2026 and is projected to hit around USD 1,712.5 trillion by 2035 with a CAGR of 32.62% from 2026 to 2035.
September 2026
The continuous renal replacement therapy market size was USD 1.71 billion in 2026, with leading continuous renal replacement therapy market players including baxter international inc, nikkiso co. ltd, infomed sa, Medtronic plc, bellco.
September 2026
The healthcare business intelligence market size reached USD 12.95 billion in 2026, with leading healthcare business intelligence market companies including ibm corporation, Microsoft, oracle, sap se, sas institute.
August 2026
The global healthcare CRM market size is expected to increase from USD 18.76 billion in 2025 to hit around USD 46.68 billion by 2035, with a CAGR of 9.54%.
August 2026
The home infusion therapy market size was valued at USD 41.83 billion in 2025 and is projected to hit around USD 90.65 billion by 2035 with a CAGR of 8.04%.
July 2026
The global continuous renal replacement therapy consumables market size was evaluated at USD 920.17 million in 2025 and is predicted to hit around USD 2,069.01 million by 2035, growing at a CAGR of 8.44%.
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
June 2026
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.
June 2026
The global oncolytic virus therapy market size is evaluated at USD 3.71 billion in 2025 and is predicted to hit around USD 12.31 billion by 2035, growing at a CAGR of 12.74%.
April 2026
The autologous cell therapy market size was garnered at USD 11.43 billion in 2025 and is expected to hit around USD 60.03 billion by 2035 With a CAGR of 18.04%.
April 2026
The global post combustion carbon capture and storage market size is projected to hit around USD 37.63 billion by 2035 increasing from USD 6.71 billion in 2025, with a CAGR of 18.82%.
March 2026
The global healthcare business collaboration tools market size is projected to be worth around USD 311.26 billion by 2035 from USD 40.15 billion in 2025, with a CAGR of 22.73%.
February 2026
The global industrial decarbonization market size was evaluated at USD 23.85 billion in 2025 and is predicted to hit around USD 101.20 billion by 2035, growing at a CAGR of 15.55%.
January 2026
The global point-of-care infectious disease diagnostics market size is projected to hit around USD 25.66 billion by 2035, with a CAGR of 15.26% from 2026 to 2035.
July 2025
The global personal care CMO and CDMO market size reached USD 28.02 billion in 2024 and is projected to surpass around USD 44.86 billion by 2034 with a CAGR of 4.82%.
July 2025
The global point-of-care ultrasound market size was estimated at USD 3.97 billion in 2024 and is predicted to surpass around USD 7.93 billion by 2034, with a CAGR of 7.20%.
July 2025
The global healthcare fraud detection market size reached USD 2.27 billion in 2024 and is predicted to be worth around USD 7.33 billion by 2034, with a notable CAGR of 12.44%.
July 2025
The global antibody therapy market size reached USD 313.47 billion in 2024 and is predicted to surpass around USD 973.60 billion by 2034, with a solid CAGR of 12%.
July 2025
The physiotherapy services market size is estimated to surpass around USD 97.11 billion by 2034 increasing from USD 57.91 billion in 2024, growing at a CAGR of 5.31%.
January 2025
The U.S. point of care infectious disease testing market size is projected to hit around USD 5.27 billion by 2035, growing at a CAGR of 8.98% from 2026 to 2035.
September 2026
The healthcare analytics market size was calculated at USD 78.30 billion in 2026 and is projected to hit around USD 427.18 billion by 2035 with a CAGR of 20.81%.
September 2026
The global salt therapy market size is projected to surpass around USD 20.57 billion by 2035 increasing from USD 9.39 billion in 2026, with a CAGR of 9.12%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com